Form 485BXT AIM COUNSELOR SERIES
As Filed
with the United States Securities and Exchange Commission on December 9, 2022.
1933 Act
Registration No. 333-36074
1940 Act Registration No. 811-09913
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
N-1A
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 |
☒ |
Pre-Effective Amendment No. |
☐ |
Post-Effective Amendment No. 173 |
☒ |
and/or
REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 |
☐ |
Amendment No. 174 |
☒ |
AIM
COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST)
(Exact Name of Registrant as Specified in
Charter)
11 Greenway Plaza, Suite 1000, Houston, TX 77046-1173
(Address of Principal Executive Office)
Registrant’s Telephone Number, including Area Code: (713) 626-1919
Jeffrey H. Kupor, Esquire
11 Greenway Plaza, Suite 1000, Houston, TX 77046
11 Greenway Plaza, Suite 1000, Houston, TX 77046
(Address of Principal Executive Office)
Copy to:
Taylor V. Edwards, Esquire
Invesco Advisers, Inc. 225 Liberty Street, 15th FL
New York, NY 10281-1087 |
Matthew R. DiClemente, Esquire
Mena M. Larmour, Esquire Stradley Ronon Stevens & Young, LLP 2005 Market Street, Suite 2600
Philadelphia, Pennsylvania 19103-7018 |
Approximate Date of Proposed Public Offering: As soon as practicable after the effective date of this Amendment.
It is proposed that this filing will become effective (check appropriate box) | |
__ |
immediately upon filing pursuant to paragraph (b) |
X |
on January 8, 2023 pursuant to paragraph (b) |
__ |
60 days after filing pursuant to paragraph (a) |
__ |
on (date) pursuant to paragraph (a) |
__ |
75 days after filing pursuant to paragraph (a)(2) |
__ |
on (date) pursuant to paragraph (a)(2) of rule 485 |
If appropriate, check the following box: | |
X |
This post-effective amendment designates a new effective date for a previously filed post-effective amendment. |
This post-effective amendment relates only to the Class A, Class C, Class R, Class Y and Class R5 shares of Invesco NASDAQ 100
Index Fund series of the Registrant (the “Fund”) as described in the Explanatory Note below. No information relating to the Registrant’s other series is amended or superseded hereby.
EXPLANATORY NOTE
Post-Effective Amendment No. 134 to the Registrant’s Registration Statement under the Securities Act of
1933, as amended (the “Securities Act”) (Amendment No. 135 under the Investment Company Act of 1940, as amended (the “Investment Company Act”))
(“PEA No. 134”), was filed with the U.S. Securities and Exchange Commission via the EDGAR system pursuant to Rule 485(a)(1) under the Securities Act on July 28, 2020, EDGAR Accession No. 0001137439-20-000666, relating to the Class A, Class C, Class R, Class Y and Class R5 shares of Invesco NASDAQ 100 Index Fund (the “Fund”).
Pursuant to Rule 485(b)(1)(iii) under the Securities Act, this Post-Effective Amendment No. 173 to the Registrant’s Registration Statement under the Securities Act (Amendment No. 174 under the Investment Company Act) (“PEA No. 173”) is being filed solely for the purpose of designating January 8, 2023, as the new effective date for PEA No. 134. The effectiveness of PEA No. 134 was delayed previously pursuant to Post-Effective Amendment Nos. 140, 141, 142, 144, 145, 146, 147, 148, 150, 151, 153, 154, 155, 156, 157, 158, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170 and 171 to the Registrant's Registration Statement filed on October 9, 2020, November 10, 2020, December 9, 2020, January 7, 2021, February 4, 2021, March 4, 2021, April 1, 2021 April 30, 2021, May 28, 2021, June 25, 2021, July 23, 2021, August 20, 2021, September 17, 2021, October 15, 2021, November 12, 2021, December 10, 2021, January 7, 2022, February 4, 2022, March 4, 2022, April 1, 2022, April 29, 2022, May 27, 2022, June 24, 2022, July 22, 2022, August 19, 2022, September 16, 2022, October 14, 2022 and November 10, 2022, respectively.
The Prospectus and Statement of Additional Information for the Fund’s Class A, Class C, Class R, Class Y and Class R5 shares included in PEA No. 134 are incorporated by reference into this PEA No. 173.
The Part C of the Registrant’s Registration Statement included in
Post-Effective Amendment No. 172 to the Registrant’s Registration Statement under the Securities Act (Amendment No. 173 under the Investment Company Act), filed on December 5, 2022, EDGAR Accession No. 0001680359-22-000237, is incorporated by reference into this PEA No. 173.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, and the Investment Company Act of 1940, as amended, the Registrant certifies that it meets all of the requirements for effectiveness of this Registration Statement under Rule 485(b) under the Securities Act of 1933, as amended, and has duly caused this Amendment to its Registration Statement to be signed on its behalf by the undersigned, duly authorized, in the city of Houston, Texas, on the 9th day of December, 2022.
AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST) | |
By: |
/s/ Sheri Morris |
|
Sheri Morris |
Title: |
President |
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed below by the following persons in the capacities indicated on the dates indicated.
SIGNATURE
|
TITLE
|
DATE |
/s/ Sheri Morris |
President |
December 9, 2022 |
(Sheri Morris) |
(Principal Executive Officer) |
|
/s/ Beth Ann Brown*** |
Chair and Trustee |
December 9, 2022 |
(Beth Ann Brown) |
|
|
/s/ Martin L. Flanagan* |
Vice Chair and Trustee |
December 9, 2022 |
(Martin L. Flanagan) |
|
|
/s/ Cynthia Hostetler* |
Trustee |
December 9, 2022 |
(Cynthia Hostetler) |
|
|
/s/ Eli Jones* |
Trustee |
December 9, 2022 |
(Eli Jones) |
|
|
/s/ Elizabeth Krentzman*** |
Trustee |
December 9, 2022 |
(Elizabeth Krentzman) |
|
|
/s/ Anthony J. LaCava, Jr.** |
Trustee |
December 9, 2022 |
(Anthony J. LaCava, Jr.) |
|
|
/s/ Prema Mathai-Davis* |
Trustee |
December 9, 2022 |
(Prema Mathai-Davis) |
|
|
/s/ Joel W. Motley*** |
Trustee |
December 9, 2022 |
(Joel W. Motley) |
|
|
/s/ Teresa M. Ressel* |
Trustee |
December 9, 2022 |
(Teresa M. Ressel) |
|
|
/s/ Robert C. Troccoli* |
Trustee |
December 9, 2022 |
(Robert C. Troccoli) |
|
|
/s/ Daniel S. Vandivort*** |
Trustee |
December 9, 2022 |
(Daniel S. Vandivort) |
|
|
/s/ Adrien Deberghes |
Vice President & |
December 9, 2022 |
Adrien Deberghes |
Treasurer
(Principal Financial Officer) |
|
|
|
|
/s/ Sheri Morris |
|
December 9, 2022 |
Sheri Morris |
|
|
Attorney-In-Fact |
|
|
*Sheri Morris, pursuant to powers of attorney dated March 28, 2018, filed in the Registrant’s Post-Effective Amendment No. 120 on August 27,
2019.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aubex Therapeutics Launches to Revolutionize Cancer Treatment with Novel Compounds directed toward the Tumor Microenvironment
- Targeted Oncology™ announces first recipient of 2024 for its Oncology Icons award program
- Hudbay to Host Conference Call for First Quarter 2024 Results
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!